February 1, 2022 - Fujifilm (Thailand) Co. Ltd. has reinforced its position of No. 1 in Total Medical Imaging Solutions by utilizing using state-of-the-art technology and innovation that not only can it solve health issues of the Thai society, but also allowing doctors to diagnose faster and more accurately by using medical information systems and the highest performing medical devices and equipment such as digital mobile X-ray machines, ultrasound machines, endoscope systems and digital mammography machines. It also includes CT scans and MRIs of Fujifilm Healthcare Corporation, a merger with Hitachi Healthcare's imaging diagnostics business in 2021. Fujifilm has also reaffirmed its vision and commitment in its relentless innovating medical solutions through the NEVER STOP campaign.
Due to the prolonged COVID-19 pandemic, Fujifilm, as a fully integrated medical company, responds to the epidemic situation of COVID-19 with Prevention, Diagnosis and Treatment. For Prevention, Fujifilm invents and manufactures the FUJIFILM COVID-19 Ag Test, which is a rapid diagnostic test for COVID-19 antigens (Professional Use) and the Hydro Ag+, which is alcohol spray products. For Diagnostic, Fujifilm introduces the medical AI technology “REiLI” to enhance the performance of FDR Nano, a digital mobile X-ray machine that can quickly and accurately detect lung abnormalities and inflammations. This allows for more efficient patient screening. For Treatment, Fujifilm develops and manufactures Avigan, an antiviral drug that is widely used in the treatment for COVID-19 virus.
With innovative and comprehensive medical solutions, Fujifilm is devoted to being a part of promoting the well-being of Thai people and relieving the burden of doctors and healthcare professionals. One of its past activities was the participation in the 46th Annual Scientific Congress of the Royal College of Surgeons of Thailand (RCST), where Fujifilm presented Total Endoscopy Solutions that can greatly enhance the endoscopic workflow. Those solutions included the Eluxeo 7000 Endoscopy system, which is the Gastrointestinal Endoscopy System, CADEYE which is the AI technology for colon cancer detection by endoscopy, and Envision Next Solutions which is the system that improve endoscopic workflows efficiently.
In the 29th Academic Conference of the Thai Society of Radiological Technologists (TSRT), Fujifilm presented the solutions in response to the COVID-19 outbreak. This included the FDR Nano, a digital mobile X-ray machine equipped with REiLI, the AI technology that can help healthcare professionals quickly and accurately detect lung abnormalities, and the FUJIFILM COVID-19 Ag Test, a rapid diagnostic test for Covid-19 antigens (Professional Use).
In addition, to reinforce its commitment in the mission to help improve for the healthier Thai society, Fujifilm donated the FUJIFILM COVID-19 Ag Test, a rapid diagnostic test for COVID-19 (Professional Use), to hospitals, volunteer groups and organizations as follows:
- Ministry of Industry for the distribution to Phramongkutklao Hospital, Srithanya Hospital, Chulalongkorn Hospital, Monk Hospital and Thammasat University Hospital (together with the Embassy of Japan in Thailand), 5,000 sets.
- The Medical Technical Council, 2,500 sets.
- Zendai, a Volunteer Group , 1,500 sets.
- The Faculty of Medical Technology, Mahidol University, 1,000 sets.
- Office of Public Health, Ratchaburi Province, 1,000 sets.
- Tuberculosis Center, District 10, Chiang Mai, 1,000 sets.
- Triam Udom Suksa Nomklao School, 500 sets.
- Mueang Pattaya Municipality, 500 sets.
- Wachirawut Camp Hospital, Nakhon Si Thammarat Province, 300 sets.
- Public Health Service Center 7, 300 sets.
The main purpose was to help prevent the spread of the COVID-19 virus at an early stage, effectively reduce the number of the people infected with COVID-19 in Thailand, alleviate the workload of the front-line medical staff and personnel for Thailand to survive the Covid-19 crisis, and create healthier Thai society. This is a mission that Fujifilm has always adhered to.